Skip to main content
Industry Resources
Displaying 1 - 12 of 448
Display:
12
24
48
Liver Tumours
What can real-world data teach us about treating patients with unresectable HCC?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Cholestatic Pruritus in Primary Biliary Cholangitis (PBC): Assessment and Management Guide
Infographics
View
Immune-Mediated and Cholestatic Diseases
Current Therapies: Patients with PBC Pruritus
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Collaborative Care: Strengthening the Healthcare Provider-Patient Partnership in PBC
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Elevating Care for Individuals with Pruritus in PBC
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Living with Cholestatic Pruritus in PBC: A Patient’s Perspective
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Switching focus: Cholestatic Pruritus in PBC
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Navigating PBC: Effective Strategies for Managing Pruritus and Fatigue
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Guiding your Patients: Addressing Cholestatic Pruritus in PBC
Webcasts
View
Viral Hepatitis
Exploring Functional Cure in Chronic Hepatitis B
Webcasts
View
Viral Hepatitis
Quantitative hepatitis B surface antigen (qHBsAg) is a useful biomarker for Chronic Hepatitis B
PDF
View
Viral Hepatitis
GSK: Time to rethink chronic hepatitis B: Quantitative hepatitis B surface antigen today and tomorrow (Complete Session)
Webcasts
View
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Privacy Policy
Cookie Policy